ATP13A3 and neuroblastoma: Reminiscent of ATP13A3 silencing, a sublethal dose of AMXT 1501 also sensitized MYCN‐amplified and non‐MYCN‐amplified neuroblastoma cells to DFMO in colony formation assays (Fig. 8A).